Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Annals of Surgical Oncology|May 27, 2024
Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 MelanomasAlec A Winder, Zoe Boyer, Sydney Ch'ng, et al.
BMJ Open|March 1, 2020
Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods studyFrances Rapport, Andrea L Smith, Anne E Cust, et al.
Nature Medicine|June 21, 2024
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trialGeorgina V Long, Matteo S Carlino, George Au-Yeung, et al.
Annals of Surgical Oncology|August 4, 2021
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAndrew T Li, Kavita Vakharia, Serigne N Lo, et al.
Journal of Translational Medicine|April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approachYizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sitesJordan W Conway, Robert V Rawson, Serigne Lo, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Journal of Translational Medicine|September 5, 2022
Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation settingMathias Seviiri, Richard A Scolyer, D Timothy Bishop, et al.
Pageof 11